SCHEMBL13699335

SCHEMBL13699335

CN(C)c1ccc(/N=N/c2ccc(NC(=O)c3ccccn3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
ALDH1A1 P00352 3/20 0.63
GAA P10253 3/20 0.63
NPC1 O15118 10/20 0.62
RAB9A P51151 10/20 0.62
SMN1; SMN2 Q16637 7/20 0.62
MAPK1 P28482 3/20 0.62
LMNA P02545 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
RECQL P46063 1/20 0.62
MCL1 Q07820 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
TP53 P04637 2/20 0.61
SNCA P37840 2/20 0.61
KDM4E B2RXH2 2/20 0.61
MITF O75030 2/20 0.61
HPGD P15428 2/20 0.61
HTT P42858 2/20 0.61
MEN1 O00255 1/20 0.61
APP P05067 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL445048 0.92 NPC1 (0.72) MAPTALDH1A1GAANPC1RAB9A
SCHEMBL31278127 0.85 SMN1; SMN2 (0.60) MAPTALDH1A1GAANPC1RAB9A
SCHEMBL31278775 0.85 SMN1; SMN2 (0.60) MAPTALDH1A1GAANPC1RAB9A
SCHEMBL31277640 0.84 SMN1; SMN2 (0.60) MAPTALDH1A1GAANPC1RAB9A
SCHEMBL31278238 0.84 SMN1; SMN2 (0.60) MAPTALDH1A1GAANPC1RAB9A
SCHEMBL16592509 0.82 NPC1 (0.56) MAPTNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL16592507 0.82 NPC1 (0.56) MAPTNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL16592611 0.82 NPC1 (0.56) MAPTNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL10892520 0.81 KCNK3 (0.65) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL10892514 0.81 KCNK3 (0.65) MAPTALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227762-A1 NOVEL CATALYTIC MATERIALS AND THEIR USE IN THE PREPARATION OF POLYMERIC MATERIALS UNIVERSITY OF LEEDS (GB) 2009-09-10 US disclosed
US-20090227762-A1 NOVEL CATALYTIC MATERIALS AND THEIR USE IN THE PREPARATION OF POLYMERIC MATERIALS UNIVERSITY OF LEEDS (GB) 2009-09-10 US disclosed
WO-2007052009-A1 NOVEL CATALYTIC MATERIALS AND THEIR USE IN THE PREPARATION OF POLYMERIC MATERIALS UNIVERSITY OF LEEDS (GB) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227762-A1 NOVEL CATALYTIC MATERIALS AND THEIR USE IN THE PREPARATION OF POLYMERIC MATERIALS LDHA, LDHB, ALAD MAPT 436/4885ALDH1A1 216/4885GAA 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.